Raymond James Financial
SRDX

Raymond James Financial’s Surmodics SRDX Stock Holding History

Raymond James Financial’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-244
Closed -$7.25K – 6533
2025
Q2 		$7.25K Buy
+244
New +$7.03K ﹤0.01% 6049

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's SRDX Position: Q3 2025 in Review

Raymond James Financial sold out of Surmodics (SRDX) in Q3 2025, closing a stake of 244 shares — an estimated $7.25K sold.

Raymond James Financial first reported a position in SRDX in Q2 2025 and held it in 1 quarter. The position peaked at $7.25K in Q2 2025. 146 funds tracked by Wall St. Rank hold SRDX as of Q3 2025.

  • Raymond James Financial reported no remaining Surmodics position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 244 Surmodics shares in Q3 2025, an estimated $7.25K.
  • Raymond James Financial first reported a position in Surmodics in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Surmodics position peaked at $7.25K in Q2 2025.
  • 146 funds tracked by Wall St. Rank held Surmodics as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.